泰達股份(000652.SZ):擬進行組織架構調整 將“投資II部”更名為“碳中和技術中心”
格隆匯9月29日丨泰達股份(000652.SZ)公佈,公司第十屆董事會第五次(臨時)會議決議,審議通過關於調整公司組織架構暨變更部門名稱及職能的議案;
為提升公司“雙碳”政策研究實力及研發能力,做大做強生態環保第一主業,公司擬進行組織架構調整,將“投資II部”更名為“碳中和技術中心”,並部門職能新增政策研究與技術研發的職能,保持投資管理職能不變;將投資I部更名為“投資管理部”,部門職能不變。
董事會認為,此次調整組織架構,有助於公司提高研發技術賦能,有助於提高生態環保產業投資管理水平,有助於公司進一步把握市場機遇、做優做強生態環保主業,同意該議案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.